Page 7 - Immunizations News Today

Clinicians should still consider prescribing the drug to adults over age 65 or those who are immunocompromised, experts said.

A recent ASCO guideline provides recommendations for routine and additional vaccinations for adults with solid tumors or hematologic malignancies as well as their household contacts.

People in Israel and Bahrain are losing their vaccination status for not taking boosters : Rashtra News A paramedic with Israel's Magen David Adom medical service administers the third shot of the Pfizer-BioNTech Covid-19 vaccine on August 24, 2021 in Holon.Ahmad Gharabli | AFP | Getty ImagesIsrael and Bahrain want eligible residents to take their

Data suggested that the vaccine reduces the risk for infection and reduces mortality rates by half.

Guggenheim analysts initiated coverage of drug firm Pfizer at Buy with a $36 price target. Shares have lagged behind the market in recent years.

Moderna on Thursday reported a surprise fourth-quarter profit even as its COVID product sales continue to plunge.

Novavax reaches a settlement related to an advance purchase agreement with Gavi.

Moderna shares were falling after the biotech revealed data that might hurt its vaccine’s competitive position.

Compared with controls, women with heavy menstrual bleeding were more likely to have received their last dose of mRNA vaccine in the previous 1-3 months in a recent study.

Merck on Thursday reported fourth-quarter earnings and sales that beat analyst expectations, powered by strong growth in cancer and vaccine products.